Precigen (PGEN) 2025 Earnings Outlook: What to Watch
As biotech earnings season unfolds, Precigen (PGEN) 2025 earnings take center stage. This guide breaks down what to m...
Timing conversions into stablecoins can protect gains during drawdowns. This piece outlines indicators and decision points for choosing pivots.
10,055 articlesAs biotech earnings season unfolds, Precigen (PGEN) 2025 earnings take center stage. This guide breaks down what to m...
Barclays has set a $7 price target on Teladoc as the company eyes growth from BetterHelp's insurance transition and s...
A keynote from Nvidia's founder signals a major shift for AI hardware and software. This could change the game for Nv...
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
If you’re building a retirement roadmap, long-horizon stock bets can compound your wealth. Here are two healthcare-fo...
Amazon launches a $200 billion AI-focused capex plan for 2026, with Trainium and Anthropic in the mix. Here’s what in...
When a company releases its quarterly earnings, investors gain a window into strategy and execution. This guide uses ...
Timken stands at a pivotal moment as it reports Q1 2026 earnings. This guide breaks down the business mix, growth dri...
AI stocks soared for years, then faced a rigorous test as valuations and demand shifted. This article breaks down wha...
Coty is navigating a shifting beauty market. This guide breaks down coty (coty) 2026 earnings, what the Q3 transcript...
Warner Bros Discovery's 2026 earnings call transcript offers more than quarterly figures. This analysis breaks down t...
Keystone reveals a sizable new stake in the IDEF defense ETF, signaling growing investor interest in defense and indu...